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Respiratory syncytial virus (RSV) encodes several proteins that lack well-defined functions; these include NS1, NS2, SH,
and M2-2. Previous work has demonstrated that NS2, SH, and M2-2 can each be deleted from RSV genome and thus are
considered as accessory proteins. To determine whether RSV can replicate efficiently when two or more transcriptional units
are deleted, we removed NS1, NS2, SH, and M2-2 genes individually and in different combinations from an infectious cDNA
clone derived from human RSV A2 strain. The following six mutants with two or more genes deleted were obtained:
DNS1NS2, DM2-2SH, DM2-2NS2, DSHNS1, DSHNS2, and DSHNS1NS2. Deletion of M2-2 together with NS1 was detrimental
to RSV replication. It was not possible to obtain a recombinant RSV when all four genes were deleted. All of the double and
triple deletion mutants exhibited reduced replication and small plaque morphology in vitro. Replication of these deletion
mutants was more reduced in HEp-2 cells than in Vero cells. Among the 10 single and multiple gene deletion mutants
obtained, DM2-2NS2 was most attenuated. DM2-2NS2 formed barely visible plaques in HEp-2 cells and had a reduction of
titer of 3 log10 compared with the wild-type recombinant RSV in infected HEp-2 cells. When inoculated intranasally into cotton
rats, all of the deletion mutants were attenuated in the respiratory tract. Our data indicated that the NS1, NS2, SH, and M2-2
proteins, although dispensable for virus replication in vitro, provide auxiliary functions for efficient RSV replication. © 2000
Academic Press
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Human respiratory syncytial virus (RSV) is the most
important viral agent of serious respiratory tract disease
in infants and children worldwide (McIntosh and
Chanock, 1990). It is the prototype member of the Pneu-
movirus genus of the Paramyxoviridae family (Lamb and
Kolakofsky, 1996). RSV is an enveloped nonsegmented
negative-strand RNA virus. Virus replication involves syn-
thesis of its positive-sense RNA intermediate (anti-
genome), which then serves as a template for amplifica-
tion of the negative-sense virus genome. Although most
members of the Mononegavirales possess only five or
six transcription units, RSV contains 10 transcription
units. Each transcription unit contains the 10-nucleotide
gene start and 12- to 13-nucleotide gene end motifs for
transcription. Ten mRNAs are sequentially transcribed
from the RSV genome to produce 11 proteins in the
following order: NS1, NS2, N, P, M, SH, G, F, M2-1, M2-2,
and L. The nucleoprotein (N), phosphoprotein (P), and
the major polymerase protein (L) form the minimal viral
polymerase complex for viral RNA transcription and rep-
lication (Yu et al., 1995; Grosfeld et al., 1995). The matrix
rotein (M) is a peripheral membrane protein located
etween viral nucleocapsids and viral envelope and is
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210nvolved in virion morphogenesis. The attachment (G)
nd fusion (F) proteins are the two major viral surface
lycoproteins that are involved in virus assembly, bud-
ing, and entry.
NS1, NS2, SH, M2-1, and M2-2 are the five additional
roteins encoded by the pneumoviruses. Except for the
H (small hydrophobic) protein that has counterparts in
he rubulaviruses SV5 (He et al., 1998; Hiebert et al.,
1985) and mumps virus (Elango et al., 1989), the NS1,
NS2, M2-1, and M2-2 proteins lack obvious counterparts
in other nonsegmented negative-strand RNA viruses.
The transcripts of NS1 and NS2 are two of the most
abundantly expressed RNAs in RSV-infected cells due to
their promoter-proximal location. The NS1 gene of RSV
strain A2 is 552 nt long and encodes a protein of 139
amino acids (Collins and Wertz, 1985). The NS2 gene is
503 nt long and encodes a protein of 124 amino acids
(Collins and Wertz, 1985). The predicted amino acid se-
quences of both NS1 and NS2 do not provide obvious
clues to their function. Using a minigenome replication
system, the NS1 protein was shown to be a potent
inhibitor of viral RNA transcription and replication (Atreya
et al., 1998). The NS2 protein was also suggested to be
a transcriptional inhibitor (Atreya et al., 1998). The M2-1
and M2-2 proteins are translated from a single M2
mRNA. The 22-kDa M2-1 protein is encoded by the
59-proximal open reading frame of the M2 mRNA and
partially overlaps the second M2-2 open reading frame
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211rRSV, RSV, M2-2, SH, NS1, AND NS2(Collins and Wertz, 1985). The M2-1 protein has been
shown to be involved in transcriptional processivity (Col-
lins et al., 1995). It decreases RNA transcriptional termi-
nation and facilitates readthrough of RNA transcription at
gene junctions (Hardy and Wertz, 1998; Hardy et al.,
1999). The M2-2 protein encoded by the 39-proximal open
reading frame of the M2 mRNA, on the other hand, is a
strong inhibitor of RSV RNA transcription and replication
in a minigenome system (Collins et al., 1996).
Recovery of infectious virus from cDNA has made it
possible to manipulate the RSV genome and to study
the functions of RSV genes with molecular ap-
proaches. Using the reverse genetics method, SH,
NS2, and M2-2 have been reported to be dispensable
for RSV replication in vitro. Although the recombinant
RSV that lacked the SH gene replicated very well in
tissue culture, the SH-deficient virus exhibited site-
specific restriction in the respiratory tract of mice and
was attenuated in chimpanzees (Bukreyev et al., 1997;
Whitehead et al., 1999). The NS2 gene of both human
nd bovine RSV was dispensable for virus replication
n vitro. However, NS2-minus RSV had small plaque
orphology and exhibited reduced replication (Buch-
olz et al., 1999; Teng and Collins, 1999). Recombinant
SV that lacked M2-2 protein expression was attenu-
ted in tissue culture cells and in rodents (Jin et al.,
2000). DM2-2 virus produced significantly reduced lev-
els of genomic RNA and antigenomic RNA, but the
level of mRNA synthesis was not affected by the lack
of M2-2 (Jin et al., 2000; Bermingham and Collins,
1999). The data obtained so far suggest that M2-2 acts
as a regulator during RNA synthesis, possibly by me-
diating the switch from transcription to genome repli-
cation to facilitate virus morphogenesis.
In this study, we generated a series of gene deletion
mutants with deletions in NS1, NS2, SH, and M2-2 genes.
We showed not only that NS1, NS2, SH, and M2-2 can be
deleted from the RSV genome individually but also that
two or more genes can be removed simultaneously from
the RSV genome without affecting virus viability in vitro.
However, all of the deletion mutants displayed altered
phenotypes and showed reduced replication in tissue
culture and in cotton rats. These results indicated that
FIG. 1. Schematic diagram of full-length antigenomic cDNA. The po
corresponding genes are indicated.the accessory proteins encoded by RSV are important for
virus replication.RESULTS
Generation of various RSV gene deletion mutants
To examine the minimal gene components that are
required for RSV replication in vitro, we used reverse
genetics to delete those genes that are unique to RSV.
NS1, NS2, SH, and M2-2 were removed from a RSV cDNA
subclone through the introduced appropriate restriction
enzyme sites. The cDNA fragments with the designed
deletions were then introduced into the full-length RSV
cDNA derived from the A2 strain (Fig. 1). The deletion of
each gene from the antigenomic cDNA clone was con-
firmed by restriction enzyme digestion and by sequenc-
ing across the deletion junctions.
To recover recombinant RSV with the introduced de-
letions, the full-length RSV cDNA clone was transfected,
together with plasmids encoding the RSV N, P, and L
proteins under the control of the T7 promoter, into MVA-
T7-infected HEp-2 cells. The culture supernatants from
the transfected HEp-2 cells were used to infect fresh
Vero cells to amplify the rescued viruses. Recovery of a
deletion mutant was indicated by syncytial formation and
confirmed by immunostaining of the infected cells using
a polyclonal anti-RSV A2 serum. A total of 10 deletion
mutants were obtained (Table 1); these included four
single gene deletion mutants (DM2-2, DSH, DNS1, and
DNS2) and six mutants with two or more genes deleted
(DNS1NS2, DM2-2NS2, DM2-2SH, DSHNS1, DSHNS2,
at which the restriction enzyme sites were introduced to delete the
TABLE 1
Recovery of RSV Deletion Mutants
cDNA construct Genome length (nt) Virus recovered
rA2 15222 1
DM2-2 14988 1
DSH 14964 1
DNS1 14690 1
DNS2 14699 1
DNS1NS2 14167 1
DM2-2NS2 14465 1
DM2-2SH 14730 1
DSHNS1 14432 1
DSHNS2 14441 1
DSHNS1NS2 13909 1
DM2-2NS1 14456 2
DM2-2SHNS1NS2 13675 2
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212 JIN ET AL.and DSHNS1NS2). DSHNS1NS2 had a deletion of 1313 nt
and contained the shortest genome length among the
viable viruses we were able to rescue. DM2-2NS1 was
initially rescued in HEp-2 cells. RSV-like infectious foci
were detected by immunostaining after the first round of
passage in Vero cells. However, this virus was not am-
plified after subsequent passages in Vero cells. Thus the
removal of both M2-2 and NS1 genes simultaneously
severely debilitated the replication of RSV. Recovery of a
recombinant RSV lacking the NS1, NS2, SH, and M2-2
genes also was not successful. We made an antigeno-
mic cDNA that had the M2-1 open reading frame deleted
but were not able to recover a recombinant RSV that
lacked the M2-1 gene. All of the recovered deletion
mutants were plaque purified three times and amplified
in Vero cells. Deletions introduced into each mutant virus
was confirmed by RT–PCR using pairs of primers span-
ning the deleted regions. Sequencing of the RT–PCR
fragments further confirmed the presence of the dele-
tions.
Northern blot analysis of mRNA
Viral RNA expression of the 10 viable deletion mutants
was examined by Northern blot analysis. Total intracel-
lular RNA was extracted from virus-infected Vero cells.
RNA blots were hybridized with digoxigenin-labeled ri-
FIG. 2. Northern blot analysis of deletion mutants. Total intracellul
blotting. Northern blots were hybridized with a digoxigenin-labeled rib
mRNA and polycistronic readthrough RNAs are indicated.boprobes that hybridized specifically to the NS1, NS2,
SH, or M2-2 genes (Fig. 2). Northern blotting analysisfurther confirmed the presence of the various deletions
in the mutant viruses. The NS1-NS2 readthrough RNA
was absent from mutants lacking either NS1 or NS2
(Figs. 2B and 2C). It was noticed that viruses with a
deletion of NS1 had increased levels of NS2 mRNA.
Relatively more NS2 transcripts were produced in cells
infected with DNS1 (lane 4) and DSHNS1 (lane 10).
Analysis of viral proteins
Western blotting and immunoprecipitation were
used to analyze viral protein synthesis of the deletion
mutants. Vero cells were infected with virus at an
m.o.i. of 0.5. At 48 h postinfection, the infected cell
lysates were harvested. Protein samples were sepa-
rated by SDS–PAGE and analyzed by Western blotting
using an anti-G monoclonal antibody, a polyclonal
antibody that recognizes both the NS1 and NS2 pro-
teins, or a polyclonal anti-SH antibody (Fig. 3A). As
expected, deletion of the NS1 gene ablated expression
of the NS1 protein for mutants DNS1, DNS1NS2,
SHNS1NS2, and DSHNS1. NS2 protein was not de-
ected in cells infected with DNS2, DNS1NS2,
SHNS1NS2, and DSHNS2. The SH protein expres-
ion was abolished in cells infected with DSH, DM2-
2SH, DSHNS1NS2, DSHNS1, and DSHNS2. Noticeably,
much more NS2 protein was expressed in cells in-
s isolated from virus-infected Vero cells were subjected to Northern
specific for the M2-2 (A), NS2 (B), NS1 (C), or SH (D). Monocistronicar RNAfected with viruses that had the NS1 gene deleted
(DNS1, lane 4, and DSHNS1, lane 10), consistent with
b
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protein produced by DSH and DSHNS1 was compara-
le to that of wild-type rA2. Accumulation of NS2
rotein in cells infected with DNS1 was compared with
wild-type rA2 by Western blotting using anti-NS2 poly-
clonal antibody. NS1 was detected in rA2-infected
cells at 8 h postinfection and was absent in DNS1-
infected cells (Fig. 3B). NS2 was detected at 24 h
postinfection, but the level of the NS2 protein synthe-
sized in DNS1-infected cells was much greater than
that of rA2. Replication of DNS1 was poorer than rA2
as judged by lower amount of the N protein accumu-
lated in DNS1-infected cells (Fig. 3B, top). The protein
expression pattern of DSHNS1 was similar to that of
DNS1 (data not shown). The increased NS2 protein
expression is most likely due to more NS2 mRNA
synthesized in the infected cells (Fig. 2). Removal of
the NS1 gene translocated the NS2 gene to the 59
most proximal location, making NS2 the first RSV gene
expressed. Expression of M2-2 protein by the 10 de-
letion mutants was examined through immunoprecipi-
tation of the virus-infected cells by using a polyclonal
antibody raised against M2-2 (Jin et al., 2000). The
M2-2 protein was not detected in cells infected with
DM2-2, DM2-2SH, and DM2-2NS2 (data not shown).
The pattern of viral protein expression of the 10 dele-
tion mutants was compared with rA2 by immunopre-
FIG. 3. Expression of RSV proteins. (A) The infected Vero cell extracts
were harvested 48 h postinfection and subjected to Western blotting
with antibodies against G, NS1/NS2, or SH. (B) Time course of NS1 and
NS2 protein expression of rA2 and DNS1 viruses. The infected cell
extracts were harvested at the indicated times of postinfection, and the
Western blot was probed with anti-NS2 polyclonal antibody and anti-N
monoclonal antibodies. The positions of viral proteins are indicated.cipitation. As shown in Fig. 4, the overall polypeptide
patterns among viruses were very similar.Replication of deletion mutants in tissue culture cells
Replication of all the deletion mutants was compared
with wild-type rA2 in both HEp-2 and Vero cells. HEp-2
cells and Vero cells were infected with each mutant at an
m.o.i. of 0.2 and incubated at 35°C for 3 days. Virus titers
were quantified by plaque assay in Vero cells. As sum-
marized in Table 2, all 10 deletion mutants showed re-
duced replication in Vero cells compared with rA2, with
titer reductions ranging from 0.2-log for DM2-2 to 1.2-log
for DNS1. The titer reduction obtained for DM2-2 in Vero
cells was consistent with that reported previously under
similar growth conditions (Jin et al., 2000). In HEp-2 cells,
a significant reduction in virus titer was observed for RSV
mutants carrying the M2-2 deletion. For example, the
deletion of M2-2 by itself resulted in a 2-log titer reduc-
tion compared with rA2. DM2-2NS2, which carried an
additional NS2 deletion, was more restricted, exhibiting
a 3-log reduction in HEp-2 cells. Unexpectedly, DM2-
2SH, which had a deletion of SH as well as M2-2, had
only an approximately 0.5-log reduction in HEp-2 cells.
Mutants that contained NS1 and/or NS2 deletions had
moderate levels of reduction in replication, approxi-
mately 1-log compared with wild-type rA2. DSH had a
level of replication similar to that of rA2 in HEp-2 cells.
Plaque size for all of the deletion mutants was also
compared with that of rA2 in these two cell lines.
HEp-2 and Vero cells were infected with each deletion
mutant or rA2 and incubated under an overlay contain-
ing 13 L15 medium and 1% methylcellulose for 6 days
at 35°C. Plaques were immunostained with anti-RSV
polyclonal antibodies, and plaque size was estimated
from photographs of immunostained RSV plaques. As
shown in Table 2, plaque size reduction was observed
FIG. 4. Immunoprecipitation of viral proteins by anti-RSV antibody.
RSV-infected Vero cells (m.o.i. 5 0.5) were metabolically labeled with
35S-ProMix (100 mCi/ml) for 4 h from 14 to 18 h postinfection. Cell
lysates were immunoprecipitated with goat polyclonal anti-RSV anti-
body, separated on a 10% polyacrylamide gel, and processed for
autoradiography. The positions of each viral protein are indicated on
the right, and the molecular weight size markers are shown on the left.
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214 JIN ET AL.for all the deletion mutants in Vero cells, ranging from
10% to 50% compared with rA2. However, in HEp-2
cells, a greater reduction in plaque sizes was ob-
served for most of the deletion mutants. DM2-2 and
M2-2SH had a modest reduction in plaque size (30%
f that of rA2), whereas rA2DM2-2NS2 formed barely
isible plaques in HEp-2 cells. Interestingly, DSH ex-
ibited plaques that were slightly larger than those of
A2. The deletion of NS1 or NS2, or both, severely
ffected virus plaque formation in HEp-2 cells. The
eletion of NS1 or NS2 reduced virus plaque size to
0–20% of that of rA2. Multiple gene deletion mutants,
SHNS1, DNS1NS2, DSHNS1, and DSHNS1NS2, had
plaque sizes 5–10% of that of rA2.
Replication in cotton rats
All of the deletion mutants were evaluated for their
ability to replicate in the lower respiratory tracts of cotton
rats. Cotton rats in groups of five were inoculated with
105 pfu of virus intranasally. Four days postinoculation,
nimals were sacrificed, and their lung tissues were
arvested and homogenized for virus titration in Vero
ells. As summarized in Table 2, DSH showed a slight
eduction in replication in the lungs of cotton rats. The
eplication of DNS1, DNS2, DNS1NS2, DM2-2SH, and
DSHNS2 was attenuated by about 100-fold compared
with that of rA2. DM2-2, DM2-2NS2, DSHNS1, and
DSHNS1NS2 were very attenuated in cotton rats; the
T
Replication of RSV Deleti
Mutants
Replicationa
Vero HEp-2 Ve
rA2 6.7 6.2 10
DM2-2 6.5 4.3 7
DSH 6.3 6.0 9
DNS1 5.5 5.5 8
DNS2 6.0 5.5 9
DNS1NS2 5.7 4.5 8
DM2-2NS2 6.2 3.4 7
DM2-2SH 6.4 5.6 5
DSHNS1 6.0 5.3 5
DSHNS2 6.4 5.1 5
DSHNS1NS2 6.3 5.1 5
a HEp-2 or Vero cells were infected with mutants at m.o.i. of 0.2 for 3
ells.
b Vero and Hep-2 cells were infected with viruses as indicated and w
and plaque size was an average of five measurements taken from ph
c Cotton rats were infected with 2 3 105 pfu viruses intranasally and
f virus by plaque assay on Vero cells.replication of these mutants in the lower respiratory
tracts of cotton rats was below the limit of detection.DISCUSSION
RSV has evolved to encode several unique proteins
that are not shared by other members of the Paramyxo-
viridae family. The functions for these accessory proteins
are not well defined. In this study, we demonstrated that
not only can NS1, NS2, SH, and M2-2 be removed indi-
vidually from RSV genome but also two or even three of
these genes can be deleted from virus simultaneously in
tissue culture. M2-2 can be deleted together with either
SH or NS2; however, virus lacking both M2-2 and NS1
could not be recovered. Thus it is not possible to delete
all four of these accessory genes from the RSV genome
at the same time. Our attempts to recover RSV with M2-1
deletion have not been successful. M2-1 has been
shown to be a transcription factor that increases tran-
scription readthrough at gene junctions (Collins et al.,
1996; Hardy and Wertz, 1998; Hardy et al., 1999). This
function is essential for virus genome replication and
transcription. Thus far, five RSV gene products have been
found to be dispensable for virus replication in vitro;
these include NS1 (the present study), NS2 (Teng and
Collins, 1999; Buchholz et al., 1999; the present study),
H (Bukreyev et al., 1997; the present study), M2-2 (Ber-
mingham and Collins, 1999; Jin et al., 2000), and G (Kar-
ron et al., 1997). It is remarkable that three genes can be
deleted simultaneously without affecting virus viability in
cell culture. However, all of the RSV mutants with one or
more genes deleted exhibited various degrees of debil-
itated replication in vitro and in vivo.
ants in Vitro and in Vivo
ue sizeb
Replication in lungs of cotton ratsc
(Mean log10pfu/g 6 SE)HEp-2
100% 4.2 6 0.08
30% ,2.0
110% 3.8 6 0.25
10% 2.2 6 0.31
20% 2.2 6 0.87
5% 2.75 6 0.10
,5% ,2.0
30% 2.3 6 1.2
5% ,2.0
10% 2.76 6 0.06
10% ,2.0
nd levels of virus replication were determined by plaque assay in Vero
ubated at 35°C for 6 days. Plaques were visualized by immunostaining
hed plaques.
later, the lung tissues were homogenized and titrated for the amountABLE 2
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0%
0%
0%
0%
0%
0%
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0%
0%
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4 daysWhen NS1, NS2, or M2-2 was deleted from RSV, the
deletion mutants exhibited a greater defect in replication
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215rRSV, RSV, M2-2, SH, NS1, AND NS2in HEp-2 cells than in Vero cells. RSV surface glycopro-
teins are processed slightly differently in the human and
simian cell lines (Rouledge et al., 1986). However, Vero
cells are also known to be deficient in the interferon (IFN)
pathway (Desmyter et al., 1968). Recently it was shown
hat many of the negative-strand RNA viruses possess
n auxiliary IFN antagonist that allow them to circumvent
ellular antiviral defense mechanisms. For example, the
protein of SV5 inhibits IFN signaling by inducing the
egradation of STAT1, a component important for IFN
ignaling (Didcock et al., 1999a,b). The Sendai virus C
protein prevents the establishment of IFN-mediated an-
tiviral response and appears to be a key determinant of
Sendai virus pathogenicity (Garcin et al., 1997, 1999). For
the segmented negative-strand viruses, influenza virus
NS1 protein was shown to act as a suppressor of PKR
activation in virus-infected cells (Hatada et al., 1999). A
recombinant influenza virus containing a deletion of 38
amino acids from the N-terminus of NS1 grows to a high
titer in IFN-deficient Vero cells, but its replication is
impaired in MDCK cells. This NS12 virus is also patho-
genic in STAT12/2 mice (Egorov et al., 1998; Garcia-
Sastre et al., 1998). RSV has been found to be resistant to
the antiviral effects mediated by human MxA and type 1
IFN (Atreya and Kulkarni, 1999). It is very likely that RSV
also encodes a gene product or products that allow RSV
replication to evade host-mediated antiviral responses.
Further studies are needed to determine the role of RSV
accessory gene products in viral pathogenesis.
The NS1 protein has been suggested to be an inhibitor
of viral transcription and replication in vitro (Atreya et al.,
1998). This inhibition is seen at both the antigenomic and
genomic promoters (Atreya et al., 1998), but it is not
known whether NS1 acts on the RNA template or on the
polymerase components. The deletion of NS1 impaired
virus replication, as indicated by its reduced plaque size
and decreased virus yield. The interaction of NS1 with M
has been demonstrated previously by coimmunoprecipi-
tation of these two proteins with anti-NS1 or anti-M
antibodies (Evans et al., 1996). Because the M protein is
involved in virus assembly, it is possible that NS1 may
have a role in virion morphogenesis through its interac-
tion with M; therefore, the lack of NS1 could cause
inefficient virus budding.
The expression of RSV proteins is well regulated
through transcription attenuation at each gene junction.
NS2 is the second gene product expressed in the in-
fected cells and is less abundant. When NS1 was de-
leted, the level of NS2 expression increased substan-
tially. If NS2 is a negative transcription regulator, as
suggested by in vitro studies (Atreya et al., 1998), in-
creased NS2 expression may alter transcription regula-
tion in those mutants lacking the NS1 protein expression.
Consistent with what has been described for the NS2
deletion mutant of both human and bovine strains (Teng
and Collins, 1999; Buchholz et al., 1999), the replication ofDNS2 was decreased by approximately 10-fold com-
pared with the wild-type recombinant RSV in both Vero
and HEp-2 cells. DNS1NS2 was even more attenuated in
HEp-2 cells, as indicated by 10-fold more titer reduction
and much smaller plaque size compared with single NS1
or NS2 deletion mutants.
As reported previously (Bukreyev et al., 1997), we also
found that DSH has little effect on virus replication in
vitro. The growth of DSH in tissue culture was similar or
slightly better than that of the wild-type recombinant RSV.
Among the 10 RSV deletion mutants examined, DSH is
least attenuated in cotton rats according to its replication
in the lower respiratory tracts of cotton rats. It has been
reported that DSH is not attenuated in the upper respi-
ratory tract but is moderately attenuated in the lower
respiratory tract of chimpanzees, a host that is fully
permissive to RSV infection (Whitehead et al., 1999).
Removal of the SH gene from DNS1, DNS2, DNS1NS2,
and DM2-2 did not seem to further impair virus replica-
tion in vitro. On the contrary, the deletion of SH appeared
to partially offset poor virus replication in HEp-2 cells that
was caused by M2-2 deletion in DM2-2SH.
DM2-2 has altered replication in several human cell
lines and is attenuated in mice and cotton rats (Jin et al.,
2000). M2-2 appears to be a regulator of virus genome
replication and transcription (Jin et al., 2000; Bermingham
and Collins, 1999). Interestingly, large syncytial formation
was observed for DM2-2 but not for DM2-2SH and DM2-
2NS2 (data not shown). DM2-2 severely reduced the
level of viral genomic and antigenomic RNA, possibly by
altering the switch from mRNA synthesis to genome
replication (Jin et al., 2000; Bermingham and Collins,
1999). Similarly, greatly reduced genomic and antigeno-
mic RNA synthesis was also observed for DM2-2SH and
DM2-2NS2 (data not shown). DM2-2NS2 was very atten-
uated in vitro, as indicated by its low yield and poor
plaque formation in infected HEp-2 cells. If both M2-2
and NS2 function as transcriptional regulators at differ-
ent stages of RSV replication, their removal could have
additive debilitating effects on virus replication. Although
it was not difficult to obtain a virus with three genes
deleted (DSHNS1NS2), it has not been possible to obtain
a virus containing both M2-2 and NS1 deletions. The
virus could not survive when both M2-2 and NS1 were
deleted. It is possible that some of these accessory
proteins interact with each other to regulate virus repli-
cation. We did not examine the replication of the deletion
mutants in the upper respiratory tracts of cotton rats
because our wild-type recombinant RSV replicates
poorly in the nasal turbinates of cotton rats. Serious RSV
disease is associated with virus replication in the lower
respiratory tract. When inoculated intranasally into cot-
ton rats, all of the deletion mutants exhibited varying
degrees of attenuation in the lower respiratory tracts,
indicating that accessory proteins of RSV may be critical
for viral pathogenesis. An association of viral accessory
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216 JIN ET AL.proteins with pathogenicity and virulence has been re-
ported for other members of the paramyxoviruses (Kuro-
tani et al., 1998; Kato et al., 1997a,b; Tober et al., 1998).
e plan to evaluate the replication of these deletion
utants in a more permissive host and to investigate
hem as potential vaccine candidates.
MATERIALS AND METHODS
ells and viruses
Monolayer cultures of HEp-2 and Vero cells [American
ype Culture Collection (ATCC), Rockville, MD] were
aintained in minimal essential medium (MEM) contain-
ng 10% fetal bovine serum (FBS). Modified vaccinia virus
nkara (MVA-T7) expressing bacteriophage T7 RNA poly-
erase was provided by Dr. Bernard Moss and grown in
EK cells.
onstruction of cDNA clones containing RSV gene
eletions
To delete each RSV gene, appropriate restriction en-
yme sites were introduced at each gene junction, and
he protein-coding regions were removed from the anti-
enomic cDNA clone as described later (Fig. 1).
Construction of pA2DNS1. To delete the NS1 open
eading frame from RSV, PstI restriction enzyme sites
ere introduced at RSV nt 45 and nt 577 by site-directed
utagenesis (Quickchange mutagenesis kit; Qiagen,
tudio City, CA). Mutagenesis was performed with
ET(X/A) cDNA subclone containing the XbaI (26 nt)–
vrII (2128 nt) restriction fragment encoding the NS1,
S2, and part of the N gene of RSV. The 532-nt cDNA
ragment containing the NS1 gene and the sequences
ncoding its gene start and gene end signal was re-
oved by PstI restriction enzyme digestion. The XbaI–
vrII restriction fragment with NS1 deletion was sepa-
ated from the pET(X/A) vector and cloned into a full-
ength RSV cDNA clone (pA2) derived from RSV A2 strain
Jin et al., 1998). The antigenomic cDNA clone contained
single nucleotide change at the fourth position (C to G
n antigenomic sense) in the RSV leader region.
Construction of pA2DNS2. PstI restriction enzyme
ites were introduced at RSV nt 577 and nt 1099 in
ET(X/A). Digestion of pET(X/A) plasmid containing the
ntroduced PstI restriction enzyme sites removed a
23-nt fragment of the NS2 gene, including its gene start
nd gene end sequences. The XbaI–AvrII restriction frag-
ent with NS2 deletion was cloned into pA2 and was
esignated pA2DNS2.
Construction of pA2DSH. An SacI restriction enzyme
ite was introduced in the gene start sequence of the SH
ene (nt 4219) in a cDNA subclone pET(A/S) that con-
ained RSV sequence from nt 2128 (AvrII) to nt 4477
SacI). A unique SacI site (nt 4477) was present in the
iral sequence at the end of the SH open reading frame.igestion with SacI allowed the removal of a 257-nt
ragment containing the gene start sequence and the
ntire open reading frame of the SH gene but not the
ene stop sequence. The AvrII–SacI restriction fragment
ith SH deletion was then cloned into pA2 and was
esignated pA2DSH.
Construction of pA2DM2-2. The M2-2 open reading
rame was largely deleted from pA2 through the intro-
uced HindIII restriction enzyme sites as previously de-
cribed (Jin et al., 2000).
Construction of pA2DNS1NS2. The NS1 and NS2
genes were deleted from RSV cDNA subclone pET(X/A)
through the introduced PstI sites at RSV nt 45 and nt
1100. The XbaI–AvrII restriction fragment with a deletion
of 1055 nt was cloned into pA2, and the plasmid was
designated as pA2DNS1NS2.
Construction of pA2DM2-2SH. The SH and M2-2
genes were deleted from the full-length RSV cDNA clone
by using existing unique restriction sites. The SacI–
BamHI fragment with M2-2 deletion in pET(S/B) subclone
was removed by digestion with SacI and BamHI restric-
tion enzymes and ligated with the full-length RSV antige-
nomic cDNA clone containing the SH gene deletion
(pA2DSH). The resulting plasmid with deletions of both
SH and M2-2 was designated pA2DM2-2SH.
Construction of pA2DM2-2NS2. To delete both M2-2
and NS2 from the full-length RSV cDNA clone, the XbaI–
AvrII fragment containing a deletion of NS2 in pET(X/A)
subclone was introduced into the full-length RSV antige-
nomic cDNA clone with the M2-2 gene deletion
(pA2DM2-2). The resulting plasmid with deletions of both
M2-2 and NS2 was designated pA2DM2-2NS2.
Construction of pA2DSHNS1. To delete both SH and
NS1 from the full-length RSV cDNA clone, the XbaI–AvrII
fragment containing a deletion of NS1 was introduced
into pA2DSH. The resulting plasmid with deletions of
both SH and NS1 was designated pA2DSHNS1.
Construction of pA2DSHNS2. To delete both SH and
NS2 from the full-length RSV cDNA clone, the XbaI–AvrII
fragment with NS2 deletion was introduced into
pA2DSH. The obtained plasmid with deletions of both SH
and NS2 was designated pA2DSHNS2.
Construction of pA2DSHNS1NS2. To delete three RSV
genes (SH, NS1, and NS2) simultaneously from the full-
length RSV antigenomic cDNA clone, the XbaI–AvrII frag-
ment with deletions of NS1 and NS2 was introduced into
pA2DSH. The plasmid with SH, NS1, and NS2 deleted
was designated pA2DSHNS1NS2.
Construction of pA2DM2-2NS1. The XbaI–AvrII frag-
ment containing a deletion of NS1 was introduced into
pA2DM2-2. The antigenomic cDNA containing deletions
of both M2-2 and NS1 was designated pA2DM2-2NS1.
Construction of pA2DM2-2SHNS1NS2. The XbaI–AvrII
fragment with both NS1 and NS2 deleted was introduced
into pA2DM2-2SH. The obtained antigenomic cDNA con-
tained deletions of four RSV genes (NS1, NS2, SH, and
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217rRSV, RSV, M2-2, SH, NS1, AND NS2M2-2) in a RSV A2 backbone and was designated
pA2DM2-2SHNS1NS2.
The cDNA fragments derived from plasmids that have
undergone mutagenesis reactions were sequenced to
ensure that no other mutations were introduced inciden-
tally. Each full-length antigenomic cDNA clone contain-
ing the designed deletions was confirmed by restriction
enzyme digestion and by sequencing across the junction
of the deleted region.
Recovery of RSV gene deletion mutants
Recovery of RSV gene deletion mutants was per-
formed as described previously (Jin et al., 1998, 2000).
Infectious viruses were rescued from the transfected
HEp-2 cells and were amplified by one passage in Vero
cells before plaque purification. Each recombinant RSV
was plaque-purified three times and grown in Vero cells.
Virus titer was determined by plaque assay, which was
enumerated by immunostaining with an anti-RSV anti-
body (Biogenesis, Sandown, NH).
Northern blotting analysis
For Northern blot hybridization analysis, Vero cells in
6-well plates were separately infected with various RSV
gene deletion mutants and rA2 at an m.o.i. of 0.5 and
incubated at 35°C for 24 h. Total cellular RNA was
extracted from the infected cell monolayers by using an
RNA extraction kit (RNA STAT-60; Tel-Test, Friendswood,
TX). RNA obtained from each well was divided into four
aliquots and electrophoresed on 1.2% agarose gels con-
taining formaldehyde in quadruplicate. The RNAs were
then transferred to nylon membranes (Amersham Phar-
macia Biotech, Piscataway, NJ), and each blot was hy-
bridized with a digoxigenin-labeled riboprobe specific for
NS1, NS2, SH, or M2-2. RNAs that hybridized with ribo-
probes were visualized using Dig-Luminescent Detec-
tion Kit for Nucleic Acids (Boehringer-Mannheim, India-
napolis, IN).
Protein expression analysis by Western blotting and
immunoprecipitation
Western blotting was used to monitor viral protein
expression of the deletion mutants. Vero cells in 6-well
plates were infected with each virus at an m.o.i. of 0.5.
After 48 h of infection, the infected cells were lysed in
protein lysis buffer. The cell lysates were electropho-
resed on 17.5% polyacrylamide gels containing 0.1% SDS
and 4 M urea, and the proteins were transferred to nylon
membranes. One blot was hybridized with a polyclonal
antiserum raised against the C-terminal 12 amino acids
of NS2. This antiserum recognizes both the NS1 and NS2
proteins because the C-terminal four residues are
shared by both proteins (Evans et al., 1996). The other
blots were probed with a polyclonal anti-SH antibody or
a monoclonal antibody against the G protein. Westernblotting was performed as described previously (Jin et
al., 1996).
For immunoprecipitation analysis, Vero cells were in-
fected with each virus at an m.o.i. of 0.5 and labeled with
35S-ProMix (100 mCi/ml 35S-Cys and 35S-Met; Amersham,
Arlington Heights, IL) from 14 to 18 h postinfection. The
labeled cell monolayers were lysed with RIPA buffer, and
the polypeptides were immunoprecipitated with a poly-
clonal anti-RSV A2 serum (Biogenesis). The immunopre-
cipitated polypeptides were electrophoresed on a 10%
polyacrylamide gel containing 0.1% SDS and detected by
autoradiography.
Replication of recombinant RSV deletion mutants in
tissue culture
Plaque formation of each deletion mutant was exam-
ined by plaque assay in HEp-2 and Vero cells using an
overlay composed of 1% methylcellulose and 13 L15.
he infected cells were incubated at 35°C for 6 days, and
he plaques were enumerated by immunostaining using
polyclonal antiserum against RSV. The plaque size for
ach mutant was estimated from photographed micro-
copic images. The mean size was averaged from five
laques and compared with the averaged size of the
ild-type rA2 plaque. To compare replication of RSV
eletion mutants with wild-type rA2 in tissue culture
ells, Vero or HEp-2 cells were infected with each virus
t an m.o.i. of 0.2 and incubated at 35°C for 3 days. The
mount of virus released from the infected cells was
etermined by plaque assay in Vero cells.
irus replication in cotton rats
Each deletion mutant was compared with the wild-
ype rA2 for its ability to replicate in the lower respiratory
racts of cotton rats. Four- to 6-week-old S. hispidus
otton rats that were free of respiratory pathogens (Virion
ystems, Rockville, MD) were inoculated in groups of five
ntranasally under light methoxyflurane anesthesia with
05 pfu in a 0.1-ml inoculum of rA2 or mutant viruses. On
day 4 postinoculation, animals were sacrificed by CO2
asphyxiation, and their lungs were obtained separately.
Tissues were homogenized in 2 ml of OptiMEM, and
virus titers were determined by plaque assay in Vero
cells.
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